13-Oct-2008
Subscription Info
|
Institutional Access
|
Browse the Faculties
|
Free Trial
|
Take a Tour
|
Top 10s
|
Advanced Search
|
Faculty Member List
|
About
Search
All F1000 Medicine
Urology
Benign Prostatic...
Browse
ALL OF MEDICINE
Urology
Benign Bladder & Urethral Disorders
Benign Prostatic Hyperplasia & Prostatitis
Lower Urinary Tract: Dysfunction, Incontinence & Urodynamics
Male Infertility
Male Sexual Dysfunction
New Technology
Pediatric Urology
Stones & Endourology
Urological Infections
Related Sections
Genitourinary Cancers
Reproductive Endocrinology
Sexual Dysfunction
Sexually Transmitted Diseases (without HIV)
selected for
My F1000 Medicine
Browse > Urology > Benign Prostatic Hyperplasia & Prostatitis
Current Top 10 by F1000 Factor
/
All Time Top 10 by F1000 Factor
/
Most viewed
(from all journals)
/
Most viewed
(from specialty journals)
/
Hidden jewels
Page 1 of 4. Select Page:
1
2
3
4
>>
Display
10
/
20
/
50
papers per page
printer friendly
10 per page
20 per page
50 per page
any date
past 7d
past 14d
past 30d
past 60d
past 90d
past 180d
past 1y
past 2y
past 5y
all papers
hypotheses
new findings
confirmations
tech advances
controversial
refutation
dissenting
new on F1000
newly evaluated
F1000 factor
most evaluations
this page
selected articles
to
EndNote
Ref. Manager
RefWorks
Bibtex
ProCite
email [
Help
]
Recommended
F1000 Factor
3.0
Confirmation
Dietary Macronutrients, Cholesterol, and Sodium and Lower Urinary Tract Symptoms in Men.
Maserejian NN, Giovannucci EL, McKinlay JB
Eur Urol
2008 Aug 3 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Evangelos Liatsikos with Panagiotis Kallidonis
Evaluated 9 Oct 2008
Must Read
F1000 Factor
6.0
Hypothesis
Functional and chronic anorectal and pelvic pain disorders.
Bharucha AE, Trabuco E
Gastroenterol Clin North Am
2008 Sep
37
(3):685-96 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Philip Hanno
Evaluated 6 Oct 2008
Must Read
F1000 Factor
6.0
New Finding
Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
Yu X, Elliott SP, Wilt TJ, McBean AM
J Urol
2008 Jul
180
(1):241-5; discussion 245 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Jaspreet Sandhu
Evaluated 2 Oct 2008
Recommended
F1000 Factor
3.0
Confirmation
New Finding
A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
Stief CG, Porst H, …, Beneke M, Ulbrich E
Eur Urol
2008 Jun
53
(6):1236-44 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Stavros Gravas
Evaluated 19 Sep 2008
Recommended
F1000 Factor
3.0
Hypothesis
Long-term treatment with finasteride results in a clinically significant reduction in total prostate volume compared to placebo over the full range of baseline prostate sizes in men enrolled in the MTOPS trial.
Kaplan SA, Roehrborn CG, …, Nyberg LM, Medical Therapy of Prostatic Symptoms Research Group
J Urol
2008 Sep
180
(3):1030-2; discussion 1032-3 [
abstract on PubMed
] [
related articles
] [
full text
] [
order article
]
Selected by
| Eric Rovner with Brett Lebed
Evaluated 5 Sep 2008
Recommended
F1000 Factor
3.0
New Finding
Unusual tumours involving the prostate: radiological-pathological findings.
Chang JM, Lee HJ, …, Seong CK, Kim SH
Br J Radiol
2008 Jul 28 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Hedvig Hricak with Yulia Lakhman
Evaluated 1 Sep 2008
Recommended
F1000 Factor
3.0
Tech Advance
[The prevention of transient urinary incontinence in peri-operative period of modified holmium laser enucleation of the prostate (HoLEP)]
Takiuchi H, Nakao A, Ihara H
Hinyokika Kiyo
2008 Jul
54
(7):475-8 [
abstract on PubMed
] [
related articles
] [
order article
]
Selected by
| Peter Gilling
Evaluated 20 Aug 2008
Recommended
F1000 Factor
3.0
New Finding
The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms.
Kedia GT, Uckert S, …, Kuczyk MA, Burchardt M
World J Urol
2008 Jul 8 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Evangelos Liatsikos with Panagiotis Kallidonis
Evaluated 18 Aug 2008
Recommended
F1000 Factor
3.0
Confirmation
Intraprostatic Botulinum Toxin A Injection Inhibits Cyclooxygenase-2 Expression and Suppresses Prostatic Pain on Capsaicin Induced Prostatitis Model in Rat.
Chuang YC, Yoshimura N, …, Chiang PH, Chancellor MB
J Urol
2008 Jun 11 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| Florian Martin Erich Wagenlehner
Evaluated 17 Jul 2008
Recommended
F1000 Factor
3.0
Tech Advance
An adjustable continence therapy device for treating incontinence after prostatectomy: a minimum 2-year follow-up.
Gilling PJ, Bell DF, …, Reuther R, Fraundorfer MR
BJU Int
2008 Jun 17 [
abstract on PubMed
] [
related articles
] [
full text
]
Selected by
| William Jaffe
Evaluated 16 Jul 2008
top of page
Page 1 of 4. Select Page:
1
2
3
4
>>
Display
10
/
20
/
50
papers per page
© 2008 Medicine Reports Ltd unless otherwise stated
< info@f1000.com >
Terms and conditions
Legal info